Pathogens are too powerful for conventional air purifiers

We live in a world where pathogens dangerously disrupt every aspect of life. COVID-19 did and (continues to do) more damage than just getting people sick. Businesses closed. Graduations were canceled. Celebrations ruined. In the U.S. alone, there have been over 60 million Covid cases and over 829,000 Covid related deaths.

All types of pathogens, like viruses, bacteria, and mold, can cause major worldwide health issues. They are responsible for serious illnesses and infections, and even allergic reactions. Every year, 2.8 million bacterial infections occur in the U.S., and more than 35,000 people die. Up to 11% of people in the U.S. get the influenza flu annually. Even 93% of chronic sinus infections are attributed to mold. Excessive concentrations of bacteria, viruses, and molds can trigger asthma episodes for 15 million Americans.

 

People spend nearly 90% of their time indoors, and indoor air pollution is a top concern of the EPA. Typical indoor air contains two to five times more pollutants than outdoor air. 

Standard air purifiers clearly aren’t effective enough at destroying these pathogens. HEPA, a standard device, only collects particles that pass through its filter. Then, it uses air changes to clean pathogens in the room. 

These air changes take time. Ten to sixty minutes to be exact. By the time the cleaning is finished, people in the space could have already inhaled the pathogens.

$11.6 billion air purification market with a 10% CAGR

Puraclenz is addressing the fast-growing $11.6 billion air purification market. It’s estimated to accelerate to $22.8 billion over the next six years, with a 10% CAGR. 

Source: Grand View Research

Industry analysts created those market estimates before COVID-19 started. We can only imagine the elevated market potential since the virus took off and developed its growing number of dangerous variants.   

Several companies and technologies compete with us in the Interior Air Quality (IAQ) sector. This sector uses various technologies, including UV light-based systems, hydrogen peroxide, negative ionizers, and more.

Most competitors’ products are considered “passive” devices, which have serious drawbacks:

• Only treat air that passes through their device

• Less energy-efficient

• Regularly require expensive filters changes

• Do not clean surfaces

There is a large price range for air purification. UV robots can cost $125,000 and small HEPA products cost $99.99. Our tech exceeds both competing capabilities at a price range between $299 and $499.

Our proprietary technology offers a unique market opportunity for powerful, low-cost, and certified safe air. We believe Puraclenz is the lowest cost professional-grade system. 

The company’s patent portfolio protects the advanced PCO design. We have four issued patents and six other pending patents. Plus our mass production process uses trade secrets that allow our purifiers to produce an extraordinarily high density of ions providing an unprecedented competitive advantage in the marketplace.

Complete air purification through small, inexpensive devices

Puraclenz provides continuous cleaning coverage in large areas with low energy consumption. And it’s easy too. Just plug in the unit, run continuously, and breathe easy knowing any pathogens are being destroyed at the source. 

We believe Puraclenz is the next generation of indoor air purification. Our devices use internal UV light that reflects onto a patented titanium catalyst, generating an extraordinarily high density of positive and negatively charged ions. These ions are the heroes–– they cling to and deactivate the pathogens mid-air and on exposed surfaces.

We now sell three purifier models that clean 750, 1,500, or 3,000 square feet areas. Since Puraclenz generates no fumes or harmful chemicals and is certified ozone-free, it’s safe to use around children and pets. Our lab studies also show, when Puraclenz is used in a room, it overwhelmingly halts the growth of mold. 

Puraclenz develops, manufactures, and markets its proprietary air purification products to businesses and consumers worldwide. In the U.S., we manage all marketing, sales, and customer support activities directly. We currently sell through three distribution channels.

PCO technology has been safely purifying the air and exposed surfaces for over 40 years. We advanced the power and safety of this technology with our patented cell design. Puraclenz’s design generates an extraordinarily high density of pathogen-destroying ions without producing any harmful by-products. Hand-cleaning or HEPA filters don’t cut it. Our design kills the pollutants they miss.

Scientifically proven products with over $700,000 revenue and international distribution

Our numbers speak for themselves. Since we launched in May 2021, Puraclenz has already generated over $700,000 in revenue with thousands of installations. Many universities, luxury hotels, schools, fitness centers, grocery stores, and small businesses nationwide are using Puraclenz to clean their air and surfaces.

*Revenue of the company's subsidiary, Puraclenz, LLC.

We currently sell five SKUs through four distribution channels in the U.S., Canada, and Mexico. In the U.S., Puraclenz sells air purification equipment direct to home, business customers from Puraclenz.com, and in bulk through its team of sales reps and network of distributors. We have master distributor agreements for Canada and Mexico. 

Puraclenz has an aggressive five-year growth plan to address this accelerating market. We hope to see annual revenues of $200 million at the end.

In 2022, Puraclenz plans to introduce four more SKUs and expand worldwide distribution to Europe, Japan, India, Southeast Asia, and the Middle East. 

We project that U.S. distribution will also expand in the next two years. In 2022, Puraclenz hopes to expand distribution to online marketplaces like Amazon, Walmart.com, Rakuten, and Houzz. In 2023 and 2024, we aim that our products will be sold in home retail stores, such as Best Buy, Target, Bed Bath Beyond, Home Depot, Lowes, and more.

Global concerns of viral spread are growing. Every business and household needs better air purification. Our devices are scientifically proven to proactively reduce viruses mid-air and on exposed surfaces.  

We believe Puraclenz’s geographic, application, and technology segmentation offers a large growth potential in the air purification market. Our products are backed by a strong and experienced management team and protected by a global patent portfolio. 

This is your chance to participate in a market opportunity with disruptive technology. We’ve created a low-cost product that efficiently addresses what we feel is the biggest global health crisis in over 100 years. It feels good knowing we’re making a difference.

We’re so proud of our success with Puraclenz in just one year. Your investment will push us closer to our ambitious expansion goals in the years to come. Let’s protect people from pathogens and help them breathe easily. Join us!